Impact of three‐dimensional–printing technology guidance on surgical outcomes for retroperitoneal sarcoma: A propensity score‐matched study
Cancer · 2025
DOI: 10.1002/cncr.35452 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2025. Verfasst von Jiaxin Lin und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of …. Hauptthemen laut MEDLINE: Sarcoma, Propensity Score, Retroperitoneal Neoplasms, Printing, Three-Dimensional. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Natural Science Foundation of Guangdong Province, Science and Technology Planning Project of Guangzhou, Medical Scientific Research Fund of Guangdong Province.
Abstract (Originalsprache)
Background
The surgical treatment of retroperitoneal sarcoma (RPS) is highly challenging because of its complex anatomy. In this study, the authors compared the surgical outcomes of patients with RPS who underwent surgical resection guided by three‐dimensional (3D) printing technology versus traditional imaging.
Methods
This retrospective study included 251 patients who underwent RPS resection guided by 3D‐printing technology or traditional imaging from January 2019 to December 2022. The main outcome measures were operative time, intraoperative blood loss, postoperative complications, and hospital stay.
Results
In total, 251 patients were enrolled in the study: 46 received 3D‐printed navigation, and 205 underwent traditional surgical methods. Propensity score matching yielded 44 patients in the 3D group and 82 patients in the control group. The patients' demographics and tumor characteristics were comparable in the matched cohorts. The 3D group had significantly shorter operative time (median, 186.5 minutes [interquartile range (IQR), 130.0–251.3 minutes] vs. 210.0 minutes [IQR, 150.8–277.3 minutes]; p = .04), less intraoperative blood loss (median, 300.0 mL [IQR, 100.0–575.0 mL] vs. 375.0 mL [IQR, 200.0–925.0 mL]; p = .02), shorter postoperative hospital stays (median, 11.0 days [IQR, 9.0–13.0 days] vs. 14.0 days [IQR, 10.8–18.3 days]; p = .02), and lower incidence rate of overall postoperative complications than the control group (18.1% vs. 36.6%; p = .03). There were no differences with regard to the intraoperative blood transfusion rate, the R0/R1 resection rate, 30‐day mortality, or overall survival.
Conclusions
Patients in the 3D group had favorable surgical outcomes compared with those in the control group. These results suggest that 3D‐printing technology might overcome challenges in RPS surgical treatment. Plain Language Summary The surgical treatment of retroperitoneal sarcoma (RPS) is highly challenging because of its complex anatomy. The purpose of this study was to investigate whether three‐dimensional (3D) printing technology offers advantages over traditional two‐dimensional imaging (such as computed tomography and magnetic resonance imaging) for guiding the surgical treatment of RPS. In a group of patients who had RPS, surgery guided by 3D‐printing technology was associated with better surgical outcomes, including shorter operative time, decreased blood loss, shorter hospital stays, and fewer postoperative complications. These findings suggested that 3D‐printing technology could help surgeons overcome challenges in the surgical treatment of RPS. 3D‐printing technology has important prospects in the surgical treatment of RPS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China.
- Second Clinical Medical College, Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong, China.
- Department of General Surgery, Hernia and Abdominal Wall Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
- Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
- Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
- Department of Pathology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China.
ORCID-Profile: Jiaxin Lin
Förderung
- Natural Science Foundation of Guangdong Province
- Science and Technology Planning Project of Guangzhou
- Medical Scientific Research Fund of Guangdong Province
- National Nature Science Foundation of China
- Administration of Traditional Chinese Medicine of Guangdong Province
- The program of Guangdong Provincial Clinical Research Center for Digestive Diseases
- Guangdong Medical Research Foundation
Zitieren
APA
Lin, J., Li, Y., Feng, X., Zhang, Y., Wang, J., Liao, W., Li, H., Yi, X., Gan, W., Yuan, Z., Liu, F., Shi, L., Zeng, B., & Diao, D. (2025). Impact of three‐dimensional–printing technology guidance on surgical outcomes for retroperitoneal sarcoma: A propensity score‐matched study. Cancer. https://doi.org/10.1002/cncr.35452
Vancouver
Lin J, Li Y, Feng X, Zhang Y, Wang J, Liao W, et al. Impact of three‐dimensional–printing technology guidance on surgical outcomes for retroperitoneal sarcoma: A propensity score‐matched study. Cancer. 2025. doi:10.1002/cncr.35452
BibTeX
@article{Lin2025,
author = {Lin, Jiaxin and Li, Yingru and Feng, Xiaochuang and Zhang, Yu and Wang, Jiahao and Liao, Weilin and Li, Hongming and Yi, Xiaojiang and Gan, Wenchang and Yuan, Zhilong and Liu, Fuheng and Shi, Lishuo and Zeng, Bing and Diao, Dechang},
title = {Impact of three‐dimensional–printing technology guidance on surgical outcomes for retroperitoneal sarcoma: A propensity score‐matched study},
journal = {Cancer},
year = {2025},
doi = {10.1002/cncr.35452}
}
EUVIMED